Perrigo | PRGO - Betriebsaufwand





Betriebsaufwand Veränderung Datum
AbbVie USD 10.81B 13.45B 2025-12
Abbott USD 9.31B 104M 2026-03
Bayer EUR 10.33B 126M 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Coherus Biosciences USD 51.83M 2.48M 2025-12
Corcept Therapeutics USD 197.64M 219K 2025-12
Dr.Reddys Laboratories INR 73.6B 1.79B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
J&J USD 17.44B 1.53B 2026-03
Merck USD 10.16B 558M 2025-12
Nestle CHF 38.42B 1.33B 2025-12
Pacira USD 193.68M 27.32M 2025-12
Perrigo USD 1.03B 75.3M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 200.95M 6.51M 2025-12
Reckitt Benckiser GBP 6.26B 3.51B 2024-12
Sanofi EUR 9.31B 1.2B 2026-03
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zoetis USD 1.55B 3.85B 2025-12